Albert P Parker - Net Worth and Insider Trading

Albert P Parker Net Worth

The estimated net worth of Albert P Parker is at least $2,125 dollars as of 2023-01-29. Albert P Parker is the COO of OncoCyte Corp and owns about 5,000 shares of OncoCyte Corp (OCX) stock worth over $2,125. Details can be seen in Albert P Parker's Latest Holdings Summary section.

Transaction Summary of Albert P Parker


Albert P Parker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Albert P Parker owns 2 companies in total, including OncoCyte Corp (OCX) , and Zynerba Pharmaceuticals Inc (ZYNE) .

Click here to see the complete history of Albert P Parker’s form 4 insider trades.

Insider Ownership Summary of Albert P Parker

Ticker Comapny Transaction Date Type of Owner
OCX OncoCyte Corp 2018-08-06 Chief Operating Officer
ZYNE Zynerba Pharmaceuticals Inc 2022-02-14 Chief Legal Officer

Albert P Parker Latest Holdings Summary

Albert P Parker currently owns a total of 1 stock. Albert P Parker owns 5,000 shares of OncoCyte Corp (OCX) as of August 3, 2020, with a value of $2,125.

Latest Holdings of Albert P Parker

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OCX OncoCyte Corp 2020-08-03 5,000 0.43 2,125

Holding Weightings of Albert P Parker

Albert P Parker Form 4 Trading Tracker

According to the SEC Form 4 filings, Albert P Parker has made a total of 1 transactions in OncoCyte Corp (OCX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 5,000 shares on August 3, 2020, which cost Albert P Parker around $6,650.

Insider Trading History of Albert P Parker

Insider Trading Shares
Shares Change
Final Share
Current Price
Price Change Since Insider Trade (%)
Filing Date
OncoCyte Corp
Total 1
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Albert P Parker Trading Performance

GuruFocus tracks the stock performance after each of Albert P Parker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Albert P Parker is -2.52%. GuruFocus also compares Albert P Parker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Albert P Parker within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Albert P Parker's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Albert P Parker

Average Relative Return


Average relative return per transaction

Outperforming Transactions


1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -22.64 -2.52 236.48 201.26 -26.34
Relative Return to S&P 500(%) -27.51 -4.78 220.22 167.01 -38.64

Albert P Parker Ownership Network

Ownership Network List of Albert P Parker

No Data

Ownership Network Relation of Albert P Parker

Albert P Parker Owned Company Details

Albert P Parker Mailing Address

Above is the net worth, insider trading, and ownership report for Albert P Parker. You might contact Albert P Parker via mailing address: C/o Oncocyte Corporation, 1010 Atlantic Avenue, Suite 102, Alameda Ca 94501.